SUMMARY Patients with classical migraine investigated between attacks had significantly fewer platelet 3H-imipramine binding sites than control subjects and this finding was more marked in males than in females. There was no abnormality of binding characteristics of platelet 5-hydroxytryptamine receptors or of platelet a2-adrenoceptors. Because the reduced 3H-imipramine binding capacity was found in classical migraineurs who were investigated between attacks, it may reflect a predisposition to migraine rather than being a consequence of attacks.
Abnormalities of platelet aggregation, particularly increased aggregation, have been reported in migraineurs between attacks in response to different agents, including 5-hydroxytryptamine (5-HT) and adrenaline. ' 2 In addition, the active uptake of 5-HT by the platelets of patients with migraine has been reported to be reduced between,3 during4 and after5 attacks of migraine. We have further investigated these abnormalities of platelet function by three separate radioligand binding studies to define the various platelet receptor sites involved. 3H-yohimbine binding to intact platelets was performed to label a2-adrenoceptors which mediate noradrenaline-and adrenaline-induced platelet aggregation.67 3H-lysergic acid diethylamide (LSD) binding to platelet membranes was performed to label the receptor for 5-HT-induced shape change and aggregation.8 A site associated with the active uptake of 5 In addition, five female classical migraineurs have been studied within five days after an attack and had a mean binding capacity which was lower than female classical migraineurs between attacks and significantly lower than female controls (p < 0-05). There was no significant difference in binding affinity between the groups. The ages were satisfactorily matched (male controls: median 32 years, range 24-40 years; female controls: median 36 years, range 18-49 years; male classical migraineurs: median 32 years, range 17-50 years; female classical migraineurs: median 35 years, range 17-53 years). It is noteworthy that we found that t in 3H-imipramine binding capacity marked in male than in female migrain the control values for females were low We thank our colleagues in the Department of Neurology, Radcliffe Infirmary, for their cooperation in allowing us to study patients in their care.
